Finally, it has been shown that α-dystroglycan and β1 integrin act as receptors for perlecan in oral precancerous lesions prior to the invasion, and the perlecan-induced signals to these receptors trigger cell differentiation and proliferation of oral carcinoma cells [224]. Here, HSPG2 is linked to lip and oral cavity carcinoma.